TRADING UPDATES: DP Poland sales rise, M Winkworth cuts forecast
14th Jan 2026 21:12
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
| Price | 109.00p on 10-02-2026 at 19:40:09 |
|---|---|
| Change | 1.50p 1.4% |
| Buy | 108.50p |
| Sell | 102.50p |
| Last Trade: | Buy 39.00 at 108.50p |
| Day's Volume: | 28,376 |
| Last Close: | 109.00p |
| Open: | 108.50p |
| ISIN: | GB0001570810 |
| Day's Range | 108.50p - 109.00p |
| 52wk Range: | 57.60p - 147.50p |
| Market Capitalisation: | £85.99m |
| VWAP: | 106.92459p |
| Shares in Issue: | 78.89m |
Xaar (XAR) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 39 | 108.50p | SI Trade |
15:45:34 - 10-Feb-26 |
| Buy* | 1,463 | 108.50p | Automatic Execution |
15:45:34 - 10-Feb-26 |
| Sell* | 600 | 105.0372p | Ordinary |
15:12:17 - 10-Feb-26 |
| Buy* | 451 | 108.50p | Automatic Execution |
14:38:40 - 10-Feb-26 |
| Buy* | 4,645 | 106.94p | Ordinary |
14:26:38 - 10-Feb-26 |
| Sell* | 500 | 105.0402p | Ordinary |
14:14:24 - 10-Feb-26 |
| Buy* | 389 | 108.50p | Automatic Execution |
13:57:38 - 10-Feb-26 |
| Sell* | 1,537 | 105.323p | Negotiated Trade |
13:05:35 - 10-Feb-26 |
| Buy* | 261 | 108.50p | Automatic Execution |
13:04:14 - 10-Feb-26 |
| Buy* | 214 | 108.50p | Automatic Execution |
13:04:13 - 10-Feb-26 |
Xaar (XAR) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 14th Jan 2026 7:00 am | RNS | Trading Statement |
| 5th Jan 2026 12:28 pm | RNS | Total Voting Rights |
| 5th Dec 2025 1:15 pm | RNS | Holding(s) in Company |
| 1st Dec 2025 12:15 pm | RNS | Total Voting Rights |
| 24th Nov 2025 11:00 am | RNS | Director/PDMR Shareholding |
| 3rd Nov 2025 2:00 pm | RNS | Total Voting Rights |
| 21st Oct 2025 4:15 pm | RNS | Director/PDMR Shareholding |
| 13th Oct 2025 3:20 pm | RNS | Holding(s) in Company |
| 2nd Oct 2025 11:10 am | RNS | Director/PDMR Shareholding |
| 2nd Oct 2025 8:50 am | RNS | Director/PDMR Shareholding |